Human cytomegalovirus (HCMV) is one of the most common causes of congenital infection leading to birth defects, and a leading cause of serious illness in patients with impaired cell-mediated immunity. Helper T cell (Th) responses to HCMV proteins are likely to be important in limiting viral replication and preventing disease. Previous studies from this laboratory have demonstrated that the amino-terminal 513 amino acids of HCMV glycoprotein B (gB) can stimulate both B and T cell responses in humans. In the present study, the proliferative responses of HCMV-specific Th clones to recombinant proteins and synthetic peptides were examined to identify four Th epitopes on gp93, which represents the amino-terminal 460 amino acids of the gB polypeptide. Using clones of known HLA restriction specificity from several donors, it was shown that each HLA class II allele preferentially associates with a different epitope on gB. Five clones from two different donors recognized an epitope in the region of amino acids 250 to 264 restricted by DR4Dw14, two clones from different donors recognized an epitope in the region of amino acids 420 to 434 restricted by DR7Dw17, two clones from different donors recognized an epitope in the region of amino acids 178 to 194 restricted by DQw1 and a single clone recognized an epitope in the region of amino acids 190 to 204 restricted by DPw4. Although all peripheral blood mononuclear cells (PBMCs) expressing a particular HLA class II allele were able to present the appropriate HLA-restricted gB peptide to gB-specific Th clones, not all individuals expressing a given HLA allele exhibited PBMC responses to the corresponding gB peptide. The HLA-related differences in Th recognition of specific epitopes on gB described in this report may have important implications in virus-host interactions and vaccine strategies.
AdoriniL.,
HarveyM. A.,
MillerA.,
SercarzE. E.1979; Fine specificity of regulatory T cells. II. Suppressor and helper T cells are induced by different regions of hen egg lysozyme in a genetically non-responder mouse strain. Journal of Experimental Medicine 150:293–306
BalfourH. H.Jr,
SladeM. S.,
KalisJ. M.,
HowardR. J.,
SimmonsR. L.,
NajarianJ. S.1977; Viral infections in renal transplant donors and their recipients: a prospective study. Surgery 81:487–492
BarcinskiM. A.,
RosenthalA.1977; Immune response gene control of determinant selection. I. Intramolecular mapping of the immunogenic sites on insulin recognized by guinea pig T and B cells. Journal of Experimental Medicine 145:726–742
BastinJ.,
RothbardJ.,
DaveyJ.,
JonesI.,
TownsendA.1987; Use of synthetic peptides of influenza nucleoprotein to define epitopes recognized by class I-restricted cytotoxic T lymphocytes. Journal of Experimental Medicine 165:1508–1523
BergotB. J.,
NobleR. L.,
GeiserT.1986; Utility of trifluoro-methane sulfonic acid as a cleavage reagent in solid phase peptide synthesis. Applied Biosystems User Bulletin No 16, Peptide Synthesizer
BerkowerI.,
BuckenmeyerG. K.,
BerzofskyJ. A.1986; Molecular mapping of a histocompatibility-restricted immunodominant T cell epitope with synthetic and natural peptides: implications for T cell antigenic structure. Journal of Immunology 136:2498–2503
BoyerM.,
NovakZ.,
FotedarA.,
FragaE.,
SinghB.1990; Critical role of an amino acid residue in a T cell determinant is due to its interaction with a neighboring non-critical residue. European Journal of Immunology 9:2145–2148
CelisE.,
KarrR. W.1989; Presentation of an immunodominant T-cell epitope of hepatitis B surface antigen by the HLA-DPw4 molecule. Journal of Virology 63:747–752
CelisE.,
KarrR. W.,
DietzscholdB.,
WunnerW. H.,
KoprowskiH.1988; Genetic restriction and fine specificity of human T cell clones reactive with rabies virus. Journal of Immunology 141:2721–2728
GehrzR. C.,
MarkerS. C.,
KnorrS. O.,
KalisJ. M.,
BalfourH. H.Jr1977; Specific cell-mediated immune defect in active cytomegalovirus infection of young children and their mothers. Lancet ii:844–847
GehrzR. C.,
ChristiansonW. R.,
LinnerK. M.,
GrothK. E.BalfourH. H.1980; Cytomegalovirus vaccine: specific humoral and cellular immune responses in human volunteers. Archives of Internal Medicine 140:936–939
GehrzR. C.,
FuadS.,
LiuY.-N. C.,
BachF. H.1987; HLA class II restriction of T helper cell response to cytomegalovirus (CMV). I. Immunogenetic control of restriction. Journal of Immunology 138:3145–3151
GelukA.,
Van MeijgaardenK. E.,
JansonA. A. M.,
DrijfhoutJ. W.,
MeloenR. H.,
De Vries R. R. P.,
OttenhoffT. H. M.1992; Functional analysis of DR17(DR3)-restricted mycobacterial T cell epitopes reveals DR17-binding motif and enables the design of allele-specific competitor peptides. Journal of Immunology 149:2864–2871
GretchD. R.,
SuterM.,
StinskiM. F.1987; The use of biotinylated monoclonal antibodies and streptavidin affinity chromatography to isolate herpes virus hydrophobic proteins and glycoproteins. Analytical Biochemistry 163:270–277
GretchD. R.,
KariB.,
RasmussenL.,
GehrzR. C.,
StinskiM. F.1988a; Identification and characterization of three distinct families of glycoprotein complexes present in the envelopes of human cytomegalovirus. Journal of Virology 62:875–881
GretchD. R.,
GehrzR. C.,
StinskiM. F.1988b; Characterization of a human cytomegalovirus glycoprotein complex (gel). Journal of General Virology 69:1205–1215
Heber-KatzB.,
HansbergD.,
SchwartzR. H.1983; The la molecule of the antigen-presenting cell plays a critical role in immune response gene regulation of T cell activation. Journal of Molecular and Cellular Immunology 1:3–18
KariB.,
LussenhopN.,
GoertzR.,
Wabuke-BunotiM.,
GehrzR. C.1986; Characterization of monoclonal antibodies reactive to three biochemically distinct human cytomegalovirus glycoprotein complexes. Journal of Virology 60:345–352
KariB.,
LiuY.-N. C,
Goertz R.,
LussenhopN.,
StinskiM. F.,
GehrzR.1990; Structure and composition of a family of human cytomegalovirus glycoprotein complexes designated gC-I (gB). Journal of General Virology 71:2673–2680
KloheE. P.,
WattsR.,
BahlM.,
AlberC.,
YuW.-Y,
AndersonR.,
SilverJ.,
Gregersen P. K.,
KarrR. W.1988; Analysis of the molecular specificities of anti-class II monoclonal antibodies by using L cell transfectants expressing HLA class II molecules. Journal of Immunology 141:2158–2164
KojimaM.,
CeaseK. B.,
BuckenmeyerG. K.,
BerzofskyJ. A.1988; Limiting dilution comparison of the repertoires of high and low responder MHC-restricted T cells. Journal of Experimental Medicine 167:1100–1113
KriegerJ. I.,
KarrR. W.,
GreyH. M.,
YuW.-Y.,
O’SullivanO.,
BatovskyL.,
ZhengZ.-L.,
ColonS. M.,
GaetaF. C. A.,
SidneyJ.,
AlbertsonM.,
Del GuercioM.-F.,
ChesnutR. W.,
SetteA.1991; Single amino acid changes in DR and antigen define residues critical for peptide-MHC binding and T cell recognition. Journal of Immunology 146:2331–2340
KurataA.,
PalkerT. J.,
StreinleinR. D.,
ScearceR. M.,
HaynesB. F.,
BerzofskyJ. A.1989; Immunodominant sites of human T cell lymphotropic virus 1 envelope protein for murine helper T cells. Journal of Immunology 143:2024–2030
LiuY.-N. C.,
EckhardtJ.,
KariB.,
GehrzR. C.1988b; General characterization of human cytomegalovirus-specific proliferative CD4+ T cell clones. International Journal of Cell Cloning 2:352–364
LiuY.-N. C.,
KlausA.,
KariB.,
StinskiM. F.,
EckhardtJ.,
GehrzR. C.1991; The N-terminal 513 amino acids of the envelope glycoprotein gB of human cytomegalovirus stimulate both B and T cell immune responses in humans. Journal of Virology 65:1644–1648
MackettM.,
SmithG. L.,
MossB.1987; The construction and characterization of vaccinia virus recombinant expressing foreign genes. In DNA Cloning: A Practical Approach vol. 2 pp 191–200 Edited by
GloverD. M.
Oxford & Washington, D.C.: IRL Press;
MeyerH.,
SundqvistV. A.,
PereiraL.,
MachM.1992; Glycoprotein gp1 16 of human cytomegalovirus contains epitopes for strain-common and strain-specific antibodies. Journal of General Virology 73:2375–2383
OldstoneM. B. A.,
WhittonJ. L.,
LewickiH.,
TishonA.1988; Fine dissection of a nine amino acid glycoprotein epitope, a major determinant recognized by lymphocytic choriomeningitis virus-specific class 1-restricted H-2Db cytotoxic T lymphocytes. Journal of Experimental Medicine 168:559–570
ReinsmoenN. L.,
BachF. H.1989; T-cell-defined MHC specificity. In Scientific and Technical Aspects of the Major Histocompatibility Complex pp 109–154 Edited by
MouldeJ.M,
FawcettK. J.,
GarnerJ. J.
Arlington: American Association of Blood Banks;
RothbardJ. B.,
LechlerR. I.,
HowlandK.,
BalV.,
EckelsD. D.,
SekalyR.,
LongE. O.,
TaylorW.R,
LambJ. R.1988; Structural model of HLA-DR1 restricted T cell antigen recognition. Cell 52:515–523
RudenskyA. Y.,
Preston-HurlburtP.,
HongS. C.,
BarlowA.Janeway C. A.Jr1991; Sequence analysis of peptides bound to MHC class II molecules. Nature, London 353:622–627
SaitoT.,
GermainR. N.1988; The generation and selection of the T cell repertoire: insights from studies of the molecular basis of T cell recognition. Immunological Reviews 101:81–113
SilicianoP. J.,
LawtonT.,
KnallC.,
KarrR. W.,
BermanP.,
GregoryT.,
ReinherzE. L.1988; Analysis of host-virus interactions in AIDS with anti-gp120 T cell clones: effect of HIV sequence variation and a mechanism for CD4+ cell depletion. Cell 54:561–575
SpaeteR. R.,
ThayerR. M.,
ProbertW. S.,
MasiarzF. R.,
ChamberlainS. H.,
RasmussenL.,
MeriganT. C.,
PachlC.1988; Human cytomegalovirus strain Towne glycoprotein B is processed by proteolytic cleavage. Virology 167:207–225
TownsendA. R. M.,
RothbardJ.,
GotchF. M.,
BahadurG.,
WraithD.,
McMichaelA. J.1986; The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides. Cell 44:959–968
WhittonJ. L.,
SouthernP. J.,
OldstoneM. B. A.1988a; Analysis of the cytotoxic T cell responses to glycoprotein and nucleoprotein components of lymphocytic choriomeningitis virus. Virology 162:321–327
WhittonJ. L.,
GebhardJ. R.,
LewickiH.,
TishonA.,
OldstoneM. B. A.1988b; Molecular definition of a major cytotoxic T-lymphocyte epitope in the glycoprotein of lymphocytic choriomeningitis virus. Journal of Virology62687–695